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General procedure for synthesis of compounds 4a
A mixture of 3a (402 mg, 1.0 mmol), concentrated hydrochloric acid (2.5 mL) and EtOH (5.0 mL) was stirred at 100 o C for 12 h. After completion, the mixture was cooled to room temperature and neutralized with NaOH aqoeous solution. Then extracted with EtOAc (10.0 mL). The collected organic layer was washed with brine (10.0 mL), dried with MgSO 4 , and filtered through a pad of Celite gradually. The solvent was removed under reduced pressure, and the gathered residue was then purified by silica gel column chromatography using PE/AcOEt as an eluent.
General procedure for the synthesis of compounds 3 by using anilines as the h. Then the mixture was cooled to room temperature and poured into water (5.0 mL), extracted with EtOAc (5.0 mL x 3), dried with Na 2 SO 4 , and the solvent was removed under reduced pressure. The products 3 were purified by flash column chromatography using PE/AcOEt as an eluent.
General procedure for synthesis of compounds 1a-D2
To a 50 mL schlenk tube with 8-aminoquinoline (288.0 mg, 2.0 mmol) was added conc. DCl in D 2 O (1 equiv, 2.0 mL). Then the tube was capped and sealed. Upon completion of the reaction for 12 h at 150 o C, the mixture was cooled to room temperature and diluted with water (25 mL). After extracting with EtOAc (10 mL x 3), the combined organic layer was gradually washed with 1 M NaHCO 3 aqueous solution (3 x 15 mL) and brine (50 mL), dried with Na 2 SO 4 , and filtered through a pad of Celite. The solvent was removed under reduced pressure to afford the deuterated 8-aminoquinoline. Note that the deuterated 8-aminoquinoline was used without any purification in the following step.
To a 100 mL single-neck flask charged with CH 2 Cl 2 (6 mL) were added deuterated 8-4 aminoquinoline (2 mmol) and triethylamine (3 mmol 
Characterization of the products

N-(5-tosylquinolin-8-yl)benzamide (3a)
This compound is known; 1 
N-[5-(4-Bromo-benzenesulfonyl)-quinolin-8-yl]-benzamide (3e)
This compound is known; 3 
N-(5-((4-methoxyphenyl)sulfonyl)quinolin-8-yl)benzamide (3f)
N-(5-((4-(trifluoromethyl)phenyl)sulfonyl)quinolin-8-yl) benzamide (3g)
This compound is known; 2 white solid, 60 mg (65%) 
N-(5-((4-nitrophenyl)sulfonyl)quinolin-8-yl)benzamide (3h)
This compound is known; 4 
N-(5-((3-nitrophenyl)sulfonyl)quinolin-8-yl)benzamide (3i)
This compound is known; 2 
4-methyl-N-(5-tosylquinolin-8-yl)benzamide (3l)
This compound is known; 5 
4-methoxy-N-(5-tosylquinolin-8-yl)benzamide (3m)
This compound is known; 1 white solid, 74 mg (85%) 
4-nitro-N-(5-tosylquinolin-8-yl)benzamide(3n)
This compound is known; 1 yellow solid, 63 mg (70%); 
4-iodo-N-(5-tosylquinolin-8-yl)benzamide (3o)
N-(5-tosylquinolin-8-yl)-[1,1'-biphenyl]-2-carboxamide (3p)
3-methyl-N-(5-tosylquinolin-8-yl)benzamide (3q)
N-(5-tosylquinolin-8-yl)furan-2-carboxamide (3r)
N-(5-tosylquinolin-8-yl)cyclohexanecarboxamide (3s)
N-(5-tosylquinolin-8-yl)cyclopropanecarboxamide (3t)
This compound is known; 6 
N-(6-methoxy-5-tosylquinolin-8-yl)benzamide (3u)
N-(2-methyl-5-tosylquinolin-8-yl)benzamide (3v)
This compound is known; 2 N-(5-tosylquinolin-8-yl) 
2-chloro-
5-tosylquinolin-8-amine (4a)
This compound is known; 7 
Investigation into the mechanism of reaction
The exploration of the analogous substrates 
Radical inhibition experiment
The reaction was inhibited in the presence of the radical inhibitor TEMPO or HQ, which showed that a radical pathway should be involved. 
